Recent Company News

• 03:13 PM ET Aug 28, 2026
  

  StreetAccount Summary: Notable Drug Events expected for the week of 30-Aug

• 11:53 AM ET Aug 28, 2026
  

  StreetAccount Summary - U.S. Unusual Option Volume: VIX (2.3%) to 14.17; S&P 500 +0.4% to 7,762.12

• 09:27 AM ET Aug 28, 2026
  

  Individualized cancer immunotherapy stocks fall on BioNTech update

• 09:20 AM ET Aug 28, 2026
  

  BioNTech terminates phase 2 trial of autogene cevumeran in resected colorectal cancer following DSMB review - 6-K ($111.40, 0.00)

• 08:35 AM ET Aug 28, 2026
  

  StreetAccount Sector Summary - Healthcare Pre-Market

• 04:36 PM ET Aug 20, 2026
  

  StreetAccount Sector Summary - Healthcare Post-Market

• 04:37 PM ET Aug 27, 2026
  

  Pfizer and BioNTech announce FDA approval for XFG-adapted COVID-19 vaccine for 2026-27 season ($111.40, 0.00)

• 07:52 PM ET Aug 21, 2026
  

  StreetAccount Sector Summary - Healthcare Weekly Recap

• 09:20 AM ET Aug 20, 2026
  

  StreetAccount Summary - US Pre-market trading update